Financial results - POPPINS PHARMA SRL

Financial Summary - Poppins Pharma Srl
Unique identification code: 30848453
Registration number: J8/1698/2012
Nace: 7022
Sales - Ron
16.176
Net Profit - Ron
13.025
Employees
Open Account
Company Poppins Pharma Srl with Fiscal Code 30848453 recorded a turnover of 2024 of 16.176, with a net profit of 13.025 and having an average number of employees of - . The company operates in the field of Activitati de consultanta pentru afaceri si management having the NACE code 7022.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Poppins Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 9.440 83 1.154 11.193 16.285 4.282 7.454 18.538 12.364 16.176
Total Income - EUR 9.440 83 1.154 11.200 16.285 4.282 7.780 19.536 12.364 16.176
Total Expenses - EUR 5.564 892 2.267 11.520 19.568 1.700 6.723 6.814 984 1.100
Gross Profit/Loss - EUR 3.876 -809 -1.113 -320 -3.283 2.582 1.057 12.722 11.380 15.075
Net Profit/Loss - EUR 3.511 -811 -1.148 -477 -3.560 2.467 824 12.150 9.832 13.025
Employees 1 0 0 1 1 1 1 1 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 31.6%, from 12.364 euro in the year 2023, to 16.176 euro in 2024. The Net Profit increased by 3.248 euro, from 9.832 euro in 2023, to 13.025 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Poppins Pharma Srl

Rating financiar

Financial Rating -
POPPINS PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Poppins Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Poppins Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Poppins Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Poppins Pharma Srl - CUI 30848453

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 846 634 424 301 205 147 0 0 0 0
Current Assets 920 116 402 1.527 3.365 4.714 5.325 14.361 24.486 37.569
Inventories 0 0 0 0 860 1.273 0 0 110 0
Receivables 312 114 176 739 2.106 2.453 1.806 1.135 14.652 33.892
Cash 607 2 226 788 399 988 3.519 13.226 9.724 3.677
Shareholders Funds 45 -766 -1.902 -2.344 -5.858 -3.280 -2.384 9.758 19.560 32.477
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 1.721 1.517 2.728 4.172 9.429 8.141 7.709 4.603 4.926 4.816
Income in Advance 0 0 0 0 0 0 0 0 0 276
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7022 - 7022"
CAEN Financial Year 7022
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 37.569 euro in 2024 which includes Inventories of 0 euro, Receivables of 33.892 euro and cash availability of 3.677 euro.
The company's Equity was valued at 32.477 euro, while total Liabilities amounted to 4.816 euro. Equity increased by 13.025 euro, from 19.560 euro in 2023, to 32.477 in 2024. The Debt Ratio was 12.8% in the year 2024.

Risk Reports Prices

Reviews - Poppins Pharma Srl

Comments - Poppins Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.